Could Anise decrease the intensity of premenstrual syndrome symptoms in comparison to placebo? A double-blind...

Area of Science:

• Herbal medicine
• Women's health
• Clinical pharmacology

Background:

• Premenstrual syndrome (PMS) affects many women of reproductive age.
• Current treatments for PMS lack definitive efficacy.
• There is a need for effective and accessible PMS management strategies.

Purpose of the Study:

• To compare the efficacy of Pimpinella Anisum (Anise) versus placebo in reducing PMS symptom intensity.
• To evaluate Anise as a potential therapeutic agent for PMS.

Main Methods:

• A randomized, double-blind, placebo-controlled clinical trial was conducted.
• Participants received either 330 mg/day of Anise or a placebo for 10 days around menstruation over two cycles.
• Symptom intensity was measured using the Premenstrual Symptoms Screening Tool (PSST).

Main Results:

• Sixty-seven college students diagnosed with PMS were enrolled.
• The Anise group showed a significant decrease in PMS symptom scores after both cycles (p<0.001).
• Mean symptom scores decreased to 13.9 after the first cycle and 9.8 after the second cycle in the Anise group.

Conclusions:

• Pimpinella Anisum (Anise) demonstrated effectiveness in alleviating premenstrual syndrome symptoms.
• Anise offers a promising natural alternative for managing PMS compared to placebo.
• Further research may explore optimal Anise dosages and long-term effects for PMS relief.